logo

For the Inventor, By the Inventor

Tokyo, Japan

Takaaki Okita

This inventor holds 14 USPTO granted patents and 1 published patent application. Top assignees: Nippon Suisan Kaisha, Ltd., Bristol-Myers Squibb Compnay, Bristol-Myers Company. Active years: 1990-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaaki Okita. Retrieved from https://idiyas.com/inventor/takaaki-okita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 78.6

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 68(Granted Patents)


Company Filing History:

goldMedal7 out of 123 
 
Nippon Suisan Kaisha, Ltd.
 patents
silverMedal5 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
bronzeMedal1 out of 637 
 
Bristol-Myers Company
 patents
4. 1 out of 39 
 
Bristol-Myers Squibb
 patents

Years Active: 1990-2008

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7410997 - Tricyclic fused heterocycle compounds, process for preparing the same and use thereof (2008-08-12),
2. 6700013 - Tricyclic fused heterocycle compounds, process for preparing the same and use thereof (2004-03-02),
3. 6602898 - Tricyclic fused heterocycle compounds, process for preparing the same and use thereof (2003-08-05),
4. 6495592 - Tracheal smooth muscle relaxants (2002-12-17),
5. 6207837 - Process for producing dibenzo[b,f]thiepine derivatives (2001-03-27),
6. 6180659 - Tracheal smooth muscle relaxant (2001-01-30),
7. 5734067 - Anti-oxidative tricyclic, condensed heterocyclic compound (1998-03-31),
8. 5608044 - Pradimic acids, amides, and pradimicin derivatives (1997-03-04),
9. 5414073 - Pradimic acids, amides, and novel pradimicin derivatives (1995-05-09),
10. 5326867 - Pradimic acids, amides, and pradimicin derivatives (1994-07-05),
11. 5234920 - Antibiotic C-7 catechol-substituted cephalosporin compounds, (1993-08-10),
12. 5143911 - Antibiotic C-3 di-hydroxyphenyl substituted cephalosporin compounds, (1992-09-01),
13. 5095012 - Antibiotic C-7 catechol-substituted cephalosporin compounds, (1992-03-10),
14. 4935508 - Process for cephem prodrug esters (1990-06-19),

Title: Takaaki Okita: Innovator in Tricyclic Fused Heterocycles

Introduction

Takaaki Okita is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of tricyclic fused heterocycle compounds. With a total of 14 patents to his name, Okita's work has had a notable impact on various applications in the industry.

Latest Patents

Among his latest patents are innovative processes for preparing tricyclic fused heterocycle compounds. These compounds are represented by specific formulas, showcasing Okita's expertise in creating complex chemical structures. His work not only emphasizes the preparation of these compounds but also their potential uses in various applications.

Career Highlights

Throughout his career, Takaaki Okita has worked with esteemed companies such as Nippon Suisan Kaisha, Ltd. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the field of chemistry.

Collaborations

Okita has collaborated with notable coworkers, including Hajime Kamachi and Shuji Jinno. These partnerships have fostered a creative environment that has led to innovative solutions and advancements in their respective fields.

Conclusion

Takaaki Okita's contributions to the field of chemistry, particularly through his patents and collaborations, highlight his role as a significant inventor. His work continues to influence the development of new compounds and processes, showcasing the importance of innovation in science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…